Photo: 10'000 Hours/Getty Images
London-based women's healthcare technology company SheMed has secured $50 million in funding.
WHAT IT DOES
The women's health company offers branded GLP-1 medications and a weight management platform. It first provides individuals with a GLP-1 blood test to screen for health markers and then it tailors one's treatment plan based on their health markers.
The company's kit is delivered to a person's home, which includes a medical profile to be completed by the individual and a kit to perform an at-home blood test. An independent physician then reviews the patient's health profile and lab results and prescribes a GLP-1 medication. Progress is tracked with weekly check-ins through the company's app.
SheMed will use the funding to expand its operations in the UK, scale its medical and technology workforce, support research and patient experience initiatives, enhance its data-driven offerings and improve its clinical infrastructure.
"For more than a decade, I searched for answers to an undiagnosed health issue," Olivia Ferro, cofounder and CEO of SheMed, said in a statement.
"As a GLP-1 patient myself, I know how transformative the right diagnosis and treatment can be. We built SheMed to give women the personalised support I struggled to find: care that listens, understands and empowers."
MARKET SNAPSHOT
In August, SheMed partnered with MedTech company Tasso, which offers its Tasso+ blood collection device. SheMed integrated Tasso's blood test into its offerings.
The company was founded in April 2024.
Other companies focused on women's health in the digital space include women's telehealth company Wisp, which offers same-day appointments for women seeking treatment for sexual and reproductive health tools.
Hybrid female pelvic floor and physical therapy company Origin provides physical therapy for the pelvic floor and the whole body to improve sexual health during pregnancy, postpartum and menopause.
In March, Origin and Wisp announced a partnership to allow their members to access each other's services.
New York-based virtual women's health provider Maven Clinic is a digital reproductive health and family platform that offers fertility and family planning services, pregnancy and postpartum care, parenting and pediatric support, as well as menopause-related care.
In June, the company announced it partnered with health-tracking ring maker Oura to allow Oura Ring wearers to sync their data with the Maven platform.
Other companies in the space include Allara Health, Carrot and Progyny.
